Application 214292
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS NY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORETHIDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE | NORETHIDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE | CAPSULE;ORAL | 0.02MG;1MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65162-558 | TAYSOFY | Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-558 | TAYSOFY | Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 69238-1686 | Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate | Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate | Amneal Pharmaceuticals NY LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 67814 | ORIG | 2021-06-15 |